JAK3: A Protein Involved in Cell Signaling and Disease (G3718)

Target Name: JAK3

NCBI ID: G3718

JAK3: A Protein Involved in Cell Signaling and Disease

JAK3, also known as Janus kinase 3, is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of cell signaling, and is involved in the signaling cascade that regulates cell growth, differentiation, and survival. JAK3 is a potential drug target and has been identified as a biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The JAK3 signaling pathway is involved in the regulation of many different cellular processes, including cell growth, differentiation, and survival. It is a key regulator of the T-cell receptor (TCR), which is responsible for cell survival and proliferation. JAK3 is also involved in the regulation of cell adhesion, migration, and the cytoskeleton.

JAK3 is a protein that is expressed in a variety of tissues, including the brain, spinal cord, heart, kidneys, and liver. It is a key regulator of the immune system, and is involved in the regulation of inflammation and immune cell function. JAK3 is also involved in the regulation of cell signaling pathways that are important for many different cellular processes, including cell growth, differentiation, and survival.

JAK3 is a potential drug target because of its involvement in the regulation of many different cellular processes. It is also a biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Because of its involvement in these processes, JAK3 is a target for a variety of therapeutic approaches, including inhibition of its signaling pathway, manipulation of its expression, and use as a diagnostic marker.

In addition to its potential as a drug target, JAK3 is also a potential biomarker for a variety of diseases. Its involvement in the regulation of many different cellular processes makes it an attractive target for the development of diagnostic tests for a variety of diseases. For example, JAK3 has been used as a biomarker for cancer, including breast, ovarian, and prostate cancers. It has also been used as a biomarker for neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

In conclusion, JAK3 is a protein that is expressed in a variety of tissues throughout the body and is involved in the regulation of many different cellular processes. It is a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of JAK3 in these processes and to develop effective therapies for the treatment of these diseases.

Protein Name: Janus Kinase 3

Functions: Non-receptor tyrosine kinase involved in various processes such as cell growth, development, or differentiation. Mediates essential signaling events in both innate and adaptive immunity and plays a crucial role in hematopoiesis during T-cells development. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors sharing the common subunit gamma such as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, upon IL2R activation by IL2, JAK1 and JAK3 molecules bind to IL2R beta (IL2RB) and gamma chain (IL2RG) subunits inducing the tyrosine phosphorylation of both receptor subunits on their cytoplasmic domain. Then, STAT5A and STAT5B are recruited, phosphorylated and activated by JAK1 and JAK3. Once activated, dimerized STAT5 translocates to the nucleus and promotes the transcription of specific target genes in a cytokine-specific fashion

More Common Targets